Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- DNA sequences (2)
- National Institutes of Health (2)
- Patent and Trademark Office (2)
- Patents (2)
- ADA (1)
-
- Access to discovery (1)
- Americans with Disabilities Act (1)
- Bioethics (1)
- Brenner v. Manson (1)
- CDNA (1)
- Constitutional rights (1)
- Consumer choice (1)
- Consumers (1)
- Cost-conscious futility policies (1)
- Disability discrimination law (1)
- Disability rights (1)
- Disclosure (1)
- End-of-life treatment (1)
- Euthanasia (1)
- Expressed sequence tags (1)
- Health care (1)
- Health care rationing (1)
- Hospitals (1)
- Informed consent (1)
- Law reform (1)
- Legal opinions (1)
- Measure 16 (1)
- Medicaid (1)
- Medical futility (1)
- National Institute of Neurological Disorders and Stroke (1)
Articles 1 - 6 of 6
Full-Text Articles in Law
From Consumer Choice To Consumer Welfare, Carl E. Schneider
From Consumer Choice To Consumer Welfare, Carl E. Schneider
Articles
In trying to understand the I SUPPORT study, it may be useful to think of contemporary bioethics reform in terms of the principles of consumer protection. The central tendency of that reform (particularly in my own field-the law) has been to employ the model of consumer choice. That model sets as its purpose to allow consumers to choose the kinds of products they prefer. It seeks to accomplish that purpose primarily by supplying consumers the information they need to make choices and by insisting that they are given what they chose. Thus, for example, merchants may be required to reveal …
Helping The Grim Reaper: Oregon's Measure 16 And Three Court Cases Put Assisted Suicide On A Fast Track To Supreme Court, Yale Kamisar, N. Schuyler, T. Balmer
Helping The Grim Reaper: Oregon's Measure 16 And Three Court Cases Put Assisted Suicide On A Fast Track To Supreme Court, Yale Kamisar, N. Schuyler, T. Balmer
Articles
Last November, Oregon's voters passed by initiative the first physician-assisted suicide law in the nation. Measure 16 authorizes physicians to prescribe lethal medicaiton for competent, terminally ill adults if they make three separate requests, wait 15 days to reconsider, and get a second medical opinion of their prognosis. The new law was challenged immediately on several legal grounds; plaintiffs have won a preliminary injunction, and arguments have been scheduled in cross motions for summary jugement. Lee v. Oregon (D Or. No. 94-6467-ITO).
The Oregon court's decision will mark the fourth time in the past year that the once-obscure issue of …
At Issue: Should Active Euthanasia Be Legalized?, Yale Kamisar, Cheryl K. Smith
At Issue: Should Active Euthanasia Be Legalized?, Yale Kamisar, Cheryl K. Smith
Articles
The distinction between letting people die and killing them by lethal injection is now an integral part of the medico-legal landscape. This is the compromise we have arrived at in the struggle to take a humane approach toward seriously ill patients while still preserving as many traditional restraints against killing as we possibly can. This may be neither the logician's or the philosopher's way, but it may nevertheless be a defensible pragmatic way to do so.
Opinion Letter As To The Patentability Of Certain Inventions Associated With The Identification Of Partial Cdna Sequences, Rebecca S. Eisenberg, Robert P. Merges
Opinion Letter As To The Patentability Of Certain Inventions Associated With The Identification Of Partial Cdna Sequences, Rebecca S. Eisenberg, Robert P. Merges
Articles
You have asked for our legal opinion on the patentability of inventions claimed in U.S. patent applications 07/716,831, filed June 21, 1991 (the '831 application, or .'831"), 07/837,195, filed September 25, 1992 ("'195"), and 07/952,911, filed February 12, 1993 (."911"), all filed in the name of Craig Venter and others and assigned to the National Institutes of Health "(NIH)." We understand that NIH has abandoned these patent applications and has no present intention of filing similar applications in the future, but that NIH remains interested in the patenting of human DNA sequences from a broader public policy perspective. We have …
Reply To Comments On The Patentability Of Certain Inventions Associated With The Identification Of Partial Cdna Sequences, Rebecca S. Eisenberg, Robert P. Merges
Reply To Comments On The Patentability Of Certain Inventions Associated With The Identification Of Partial Cdna Sequences, Rebecca S. Eisenberg, Robert P. Merges
Articles
A brief reply is in order to clarify our position on the patenting of research tools. We stand by the statement that "there are reasons to be wary of patents on research tools," but that statement should not be understood as a broad condemnation of patents on research tools in all contexts. Indeed, immediately after the cited language our opinion letter acknowledges that withholding patent protection from research tools could undermine private incentives to develop research tools and to make them available to investigators or lead to greater reliance on trade secrecy. Unlike the government, which purports to pursue patent …
Medical Futility And Disability Discrimination, Mary Crossley
Medical Futility And Disability Discrimination, Mary Crossley
Articles
The concept of medical futility, which originally developed in the medical literature as a basis for allocating between physician and patient decisional authority regarding end-of-life treatment, is increasingly appearing in discussions regarding possible methods of containing medical costs by limiting treatment. This use of medical futility as a rationing mechanism, whether by a state Medicaid program or by a hospital, raises concerns regarding its impact on persons with severe disabilities near the end of life. This article considers how the applicability of the Americans with Disabilities Act to cost-conscious futility policies might be analyzed. After developing arguments that proponents and …